MAP4K4 and atherosclerosis: Therefore, while MAP4K4 likely has actions in multiple cell types to promote atherosclerosis in mice, protection from and treatment of atherosclerosis by PF-06260933 is consistent with endothelial MAP4K4 as one of multiple targets for the action of PF-06260933 to mediate these beneficial effects.